Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...
A systematic review and meta-analysis from the Harvard T.H. Chan School of Public Health reported a large effect of ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for ...
Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...
The first patient in the UK with advanced bowel cancer to receive a liver transplant after the disease spread to it has said ...
A young woman is cancer-free after undergoing the UK’s first liver transplant for advanced bowel cancer. Bianca Perea, a ...
Discover why psychiatrists are moving beyond single-treatment approaches and how combining therapies could be the key to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback